TY - JOUR
T1 - Porcine interferon-gamma protects swine from foot-and-mouth disease virus (FMDV)
AU - Yao, Qingxia
AU - Huang, Qinfeng
AU - Cao, Yi
AU - Qian, Ping
AU - Chen, Huanchun
PY - 2008/4/15
Y1 - 2008/4/15
N2 - Porcine interferon-gamma (PoIFN-γ) fused with glutathione S-transferase (GST) was expressed in Escherichia coli BL21. Twenty 6-week-old piglets were randomly assigned to four groups. Pigs in groups 1-3 were pretreated with 30 mg, 20 mg, and 10 mg recombinant PoIFN-γ (rPoIFN-γ), respectively. Pigs in group 4 (control) were pretreated with GST expressed by the empty plasmid. At 48 h postinoculation (hpi), all swine were challenged with FMDV (serotype O). Pigs pretreated with 30 mg rPoIFN-γ were completely protected from virulent FMDV attack. Pigs given 20 mg rPoIFN-γ achieved partial protection, and the unprotected piglets showed clinical signs from 68 h postchallenge (hpc). Although 10 mg rPoIFN-γ did not confer protection against FMDV, the pigs pretreated with this dose of rPoIFN-γ presented clinical signs from 35 hpc, which was later than the control group (14 hpc). These results indicate that PoIFN-γ can protect swine against attack from FMDV or delay the appearance of clinical signs; the effect is dose dependent.
AB - Porcine interferon-gamma (PoIFN-γ) fused with glutathione S-transferase (GST) was expressed in Escherichia coli BL21. Twenty 6-week-old piglets were randomly assigned to four groups. Pigs in groups 1-3 were pretreated with 30 mg, 20 mg, and 10 mg recombinant PoIFN-γ (rPoIFN-γ), respectively. Pigs in group 4 (control) were pretreated with GST expressed by the empty plasmid. At 48 h postinoculation (hpi), all swine were challenged with FMDV (serotype O). Pigs pretreated with 30 mg rPoIFN-γ were completely protected from virulent FMDV attack. Pigs given 20 mg rPoIFN-γ achieved partial protection, and the unprotected piglets showed clinical signs from 68 h postchallenge (hpc). Although 10 mg rPoIFN-γ did not confer protection against FMDV, the pigs pretreated with this dose of rPoIFN-γ presented clinical signs from 35 hpc, which was later than the control group (14 hpc). These results indicate that PoIFN-γ can protect swine against attack from FMDV or delay the appearance of clinical signs; the effect is dose dependent.
KW - Challenge
KW - Foot-and-mouth disease virus
KW - Interferon-gamma
KW - Porcine
KW - Protection
UR - http://www.scopus.com/inward/record.url?scp=40949113624&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=40949113624&partnerID=8YFLogxK
U2 - 10.1016/j.vetimm.2007.09.004
DO - 10.1016/j.vetimm.2007.09.004
M3 - Article
C2 - 17996949
AN - SCOPUS:40949113624
SN - 0165-2427
VL - 122
SP - 309
EP - 311
JO - Veterinary immunology and immunopathology
JF - Veterinary immunology and immunopathology
IS - 3-4
ER -